DNA aptamer selected for specific recognition of prostate cancer cells and clinical tissues

[1]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[2]  E. Vermaas,et al.  Selection of single-stranded DNA molecules that bind and inhibit human thrombin , 1992, Nature.

[3]  J. Thompson,et al.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.

[4]  Ying-Fon Chang,et al.  Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein* , 2001, The Journal of Biological Chemistry.

[5]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..

[6]  L. Gold,et al.  A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Bertrand Tavitian,et al.  Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase , 2005, PLoS biology.

[8]  M. Behlke,et al.  Effects of fluorescent dyes, quenchers, and dangling ends on DNA duplex stability. , 2005, Biochemical and biophysical research communications.

[9]  Kemin Wang,et al.  Selection of aptamers for molecular recognition and characterization of cancer cells. , 2007, Analytical chemistry.

[10]  Weihong Tan,et al.  Optimization and Modifications of Aptamers Selected from Live Cancer Cell Lines , 2007, Chembiochem : a European journal of chemical biology.

[11]  Weihong Tan,et al.  Molecular Recognition of Small‐Cell Lung Cancer Cells Using Aptamers , 2008, ChemMedChem.

[12]  Weihong Tan,et al.  Identification of liver cancer-specific aptamers using whole live cells. , 2008, Analytical chemistry.

[13]  Selection of RNA aptamers specific to active prostate-specific antigen , 2010, Biotechnology Letters.

[14]  Hui Chen,et al.  Molecular recognition of acute myeloid leukemia using aptamers , 2008, Leukemia.

[15]  Xiaohong Fang,et al.  Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells. , 2009, The Analyst.

[16]  Weihong Tan,et al.  DNA Aptamers as Molecular Probes for Colorectal Cancer Study , 2010, PloS one.

[17]  D. Shangguan,et al.  Conservative secondary structure motif of streptavidin-binding aptamers generated by different laboratories. , 2010, Bioorganic & medicinal chemistry.

[18]  H. Rübben,et al.  Probleme, Zielsetzung und Inhalt der Früherkennung beim Prostatakarzinom , 2010, Der Urologe.

[19]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[20]  John J Rossi,et al.  Cell-specific aptamer-mediated targeted drug delivery. , 2011, Oligonucleotides.

[21]  Shun-ichiro Ogura,et al.  Selection of DNA aptamers recognizing small cell lung cancer using living cell-SELEX. , 2011, The Analyst.

[22]  Jun Zhang,et al.  A Cell-based Single-stranded DNA Aptamer Specifically Targets Gastric Cancer. , 2013, The international journal of biochemistry & cell biology.

[23]  Yan Li,et al.  Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles. , 2013, Biomaterials.

[24]  Mohammad Hassan Murad,et al.  Early detection of prostate cancer: AUA Guideline. , 2013, The Journal of urology.

[25]  Arun Z. Thomas,et al.  Digital rectal examination in primary care is important for early detection of prostate cancer: a retrospective cohort analysis study. , 2014, The British journal of general practice : the journal of the Royal College of General Practitioners.

[26]  F. Ducongé,et al.  From Ugly Duckling to Swan: Unexpected Identification from Cell-SELEX of an Anti-Annexin A2 Aptamer Targeting Tumors , 2014, PloS one.

[27]  Nan Zhang,et al.  DNA Aptamer Evolved by Cell-SELEX for Recognition of Prostate Cancer , 2014, PloS one.

[28]  Gwo-Bin Lee,et al.  An on-chip Cell-SELEX process for automatic selection of high-affinity aptamers specific to different histologically classified ovarian cancer cells. , 2014, Lab on a chip.

[29]  H. Hricak,et al.  Molecular imaging of prostate cancer: translating molecular biology approaches into the clinical realm , 2015, European Radiology.

[30]  Timothy J Wilt,et al.  Prevention and early detection of prostate cancer. , 2014, The Lancet. Oncology.

[31]  A. Vinarov,et al.  Telomerase as a tumor marker in diagnosis of prostatic intraepithelial neoplasia and prostate cancer , 2014, The Prostate.

[32]  Kemin Wang,et al.  Single-walled carbon nanotubes (SWCNTs)-assisted cell-systematic evolution of ligands by exponential enrichment (cell-SELEX) for improving screening efficiency. , 2014, Analytical chemistry.

[33]  A DNA aptamer with high affinity and specificity for molecular recognition and targeting therapy of gastric cancer , 2014, BMC Cancer.

[34]  Yeongjin Kim,et al.  Robotic system with sweeping palpation and needle biopsy for prostate cancer diagnosis , 2014, The international journal of medical robotics + computer assisted surgery : MRCAS.

[35]  Lin-Chi Chen,et al.  Selection of aptamers for fluorescent detection of alpha-methylacyl-CoA racemase by single-bead SELEX. , 2014, Biosensors & bioelectronics.

[36]  C. Yuan,et al.  Diagnostic applications of gastric carcinoma cell aptamers in vitro and in vivo. , 2015, Talanta.

[37]  Kemin Wang,et al.  Cell-SELEX based selection and optimization of DNA aptamers for specific recognition of human cholangiocarcinoma QBC-939 cells. , 2015, The Analyst.

[38]  Weihong Tan,et al.  DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition , 2015, Theranostics.